Total medical devices industry venture financing deals worth $213m were announced in Asia-Pacific in August 2022, led by $52.57m venture financing of CureApp, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 18.6% over the previous month of $261.76m and a drop of 56.05% when compared with the last 12-month average of $484.64m.

Asia-Pacific held an 18.68% share of the global medical devices industry venture financing deal value that totalled $1.14bn in August 2022. With a 13.19% share and deals worth $150.41m, China was the top country in Asia-Pacific’s venture financing deal value across medical devices industry.

In terms of venture financing deal activity, Asia-Pacific recorded 37 deals during August 2022, marking an increase of 2.78% over the previous month and a flat growth over the 12-month average. China recorded 29 deals during the month.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Asia-Pacific medical devices industry venture financing deals in August 2022: Top deals

The top five medical devices industry venture financing deals accounted for 66.2% of the overall value during August 2022.

The combined value of the top five medical devices venture financing deals stood at $140.97m, against the overall value of $213m recorded for the month.

The top five medical devices industry venture financing deals of August 2022 tracked by GlobalData were:

1) The Carlyle Group’s $52.57m venture financing deal with CureApp

2) The $29.58m venture financing of Cygnus Biosciences (Beijing) by China State-owned Enterprise Structural Adjustment Fund Phase II and Wuxi Guolian Guokang Health Industry Investment Center

3) BASF Venture Capital (Shanghai), Jinyu Bogor Investment Management Co. and Qiming Venture Partners’s $29.19m venture financing deal with Prismlab China

4) The $14.83m venture financing of Suzhou Yatong Biomedical Technology by Borun Capital, Guolian Xinchuang, Hongshi Capital and Xingze Capital

5) Gaorong Capital, Kaitai Capital, Shanghai Lichen Private Equity Fund Management and Virtus Inspire Ventures’s $14.81m venture financing deal with Crystal Nucleus Biomedical Technology (Nanjing)